Literature DB >> 7694851

Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe.

H Chart1, N C van der Kar, J J Tolboom, L M Monnens, B Rowe.   

Abstract

Sera from 45 patients from The Netherlands, Germany and Belgium who had a clinical diagnosis of haemolytic uraemic syndrome (HUS) were screened for antibodies to the lipopolysaccharide (LPS) of Escherichia coli producing Verocytotoxin (VTEC). Sera from 43 family contacts and 34 control patients were also examined. Using the techniques of EIA and immunoblotting, antibodies to the LPS of Escherichia coli O157 were found in 28 patients, and to the LPS of serogroups O115 and O145 in one patient and one family member respectively. The results of our study suggest that VTEC, and in particular Escherichia coli O157, might be a significant cause of HUS in Western Europe.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694851     DOI: 10.1007/bf02009386

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Serological identification of Escherichia coli O157 as cause of haemolytic uraemic syndrome in Netherlands.

Authors:  H Chart; B Rowe; N vd Kar; L A Monnens
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

2.  Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome.

Authors:  H Chart; S M Scotland; H R Smith; B Rowe
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

Review 3.  Vero cytotoxin-producing strains of Escherichia coli.

Authors:  H R Smith; S M Scotland
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Authors:  H Chart; H R Smith; S M Scotland; B Rowe; D V Milford; C M Taylor
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

7.  Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group.

Authors:  A Caprioli; I Luzzi; F Rosmini; P Pasquini; R Cirrincione; A Gianviti; M C Matteucci; G Rizzoni
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

8.  High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome.

Authors:  M Bitzan; E Moebius; K Ludwig; D E Müller-Wiefel; J Heesemann; H Karch
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

9.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  2 in total

1.  Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source.

Authors:  H Tschape; R Prager; W Streckel; A Fruth; E Tietze; G Böhme
Journal:  Epidemiol Infect       Date:  1995-06       Impact factor: 2.451

2.  Complete Genome Sequences of Two Escherichia coli O145:H28 Outbreak Strains of Food Origin.

Authors:  Kerry K Cooper; Robert E Mandrell; Jacqueline W Louie; Jonas Korlach; Tyson A Clark; Craig T Parker; Steven Huynh; Patrick S G Chain; Sanaa Ahmed; Michelle Qiu Carter
Journal:  Genome Announc       Date:  2014-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.